Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit
Notifications can be managed in browser preferences.
Next article
Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A new treatment for advanced bladder cancer which doubles survival time has been approved for NHS use.
It is estimated that 1,250 people a year could benefit from the new drug
The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common…
Men with high-risk prostate cancer that has not yet spread now qualify for the treatment
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine
The disease is considered incurable and affects around 33,000 people in the UK
